Amanote Research

Amanote Research

    RegisterSign In

Caffeine and Progression of Parkinson Disease

Clinical Neuropharmacology - United States
doi 10.1097/wnf.0b013e31815a3f03
Full Text
Open PDF
Abstract

Available in full text

Categories
NeurologyPharmacology
Date

July 1, 2008

Authors
David K. SimonChristopher J. SwearingenRobert A. HauserJoel M. TrugmanMichael J. AminoffCarlos SingerDaniel TruongBarbara C. Tilley
Publisher

Ovid Technologies (Wolters Kluwer Health)


Related search

Serum Caffeine and Metabolites Are Reliable Biomarkers of Early Parkinson Disease

Neurology
Neurology
2018English

The Role of SNCA Rep1 Microsatellite in Parkinson’s Disease Progression

2017English

The Personalized Parkinson Project: Examining Disease Progression Through Broad Biomarkers in Early Parkinson’s Disease

BMC Neurology
MedicineNeurology
2019English

Gene Therapy for Parkinson Disease(Parkinson Disease)

Japanese Journal of Neurosurgery
SurgeryNeurology
2006English

Parkinson Disease and Polyneuropathy

Neurology
Neurology
2011English

Clinically Meaningful Parameters of Progression and Long-Term Outcome of Parkinson Disease: An International Consensus Statement

Parkinsonism and Related Disorders
GerontologyGeriatricsNeurology
2015English

Parkinson Disease

JAMA - Journal of the American Medical Association
Medicine
2000English

Parkinson Disease and Mortality

Neurology
Neurology
2018English

Parkinson Disease Survival

Archives of Neurology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy